Free Trial

Craneware plc (LON:CRW) Insider Buys £30,270.24 in Stock

Craneware logo with Medical background

Craneware plc (LON:CRW - Get Free Report) insider Will Whitehorn bought 1,911 shares of the business's stock in a transaction on Thursday, April 24th. The stock was purchased at an average price of GBX 1,584 ($21.01) per share, for a total transaction of £30,270.24 ($40,156.86).

Craneware Stock Performance

Craneware stock traded up GBX 40 ($0.53) during midday trading on Friday, reaching GBX 1,860 ($24.67). 128,331 shares of the company's stock were exchanged, compared to its average volume of 88,916. The stock's 50-day simple moving average is GBX 1,724.64 and its 200 day simple moving average is GBX 1,967.74. The firm has a market cap of £799.18 million, a price-to-earnings ratio of 68.72 and a beta of 0.28. The company has a debt-to-equity ratio of 12.22, a quick ratio of 1.00 and a current ratio of 0.63. Craneware plc has a 52 week low of GBX 1,330 ($17.64) and a 52 week high of GBX 2,509.20 ($33.29).

Craneware Cuts Dividend

The firm also recently declared a dividend, which was paid on Thursday, April 17th. Shareholders of record on Thursday, March 20th were issued a dividend of GBX 13.50 ($0.18) per share. This represents a yield of 0.71%. The ex-dividend date was Thursday, March 20th. Craneware's dividend payout ratio is 107.14%.

Wall Street Analyst Weigh In

CRW has been the topic of several analyst reports. Shore Capital reissued a "buy" rating on shares of Craneware in a research report on Tuesday, March 11th. Berenberg Bank reissued a "buy" rating and set a GBX 2,800 ($37.15) price target on shares of Craneware in a research report on Tuesday, March 11th.

Check Out Our Latest Research Report on Craneware

About Craneware

(Get Free Report)

The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.

Featured Articles

Should You Invest $1,000 in Craneware Right Now?

Before you consider Craneware, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Craneware wasn't on the list.

While Craneware currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines